Project cooperationUpdated on 3 December 2025
Study the impact of climate change in the development and progression of Parkinson´s disease
Head of Biomedicine and Cellular Toxicology at University of Burgos
Burgos, Spain
About
We are looking for a consortium to join and contribute investigating the impact of climate change in the development and progression of Parkinson´s disease. Our capacities include: access to clinical samples, PD biomarkers; SNP genotyping and Pharmacogenetics, digital biomarkers, as well as neurotoxicity assays in vitro and in silico; platform Implementation, Data Analysis, artificial intelligence and machine learning.
Topic
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
Patient-Derived Zebrafish Larvae Xenografts for Drug Efficacy and Stroma-Interaction Studies
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Vadims Parfejevs
Lead researcher at Department of Pharmaceutical Sciences, University of Latvia
Riga, Latvia
Project cooperation
Expertise in Human-Relevant NAMs and Advanced Safety Assessment
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Laura Gómez Cuadrado
Head of Biomedicine and Cellular Toxicology at University of Burgos
Burgos, Spain
Project cooperation
Translational NAMs in pharmacology & toxicology for drug profiling
- Partner seeks Consortium/Coordinator
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Nikolas Dietis
Assistant Professor of Pharmacology at University of Cyprus
Nicosia, Cyprus